FDA Tip-Toes In China To Push Data Integrity, Harmonization

US FDA warning letters to Chinese firms may be on the increase, but ties with the Chinese regulator appear to be growing. US FDA showcases how to get more done in fast-changing China via aligning with China FDA's aspiration for quality and international harmonization.

Large US American flag on sailboat off the coast of California

More from Clinical Trials

More from R&D